Transition from Traditional, Paper Consent to Efficient, Digital eConsent Date Published: Mar 03, 2021 Brochure Signant’s electronic consent (eConsent) solution ensures study patients comprehend the clinical trial before giving an informed consent remotely. The digital solution also efficiently manages the various form versions to ease site staff burden and improve adherence. eConsent benefits clinical trials by: Simplifying the process Enhancing participant understanding Eliminating errors We provide six reasons why you should choose SmartSignals eConsent for your next study. Plus, read about our flexible licensing and implementation options. Compare the tiered options to find the best eConsent solution for your study needs. Download Now Share: LinkedInTweet Recommended Resources Article Optimal COA Measurement Strategy in Modern Oncology Trials The inclusion of patient-reported outcomes (PRO) data in oncology medication labeling in the U.S. has been comparatively limited. Recent FDA... Read Now 3 Themes and Takeaways From FDA’s Draft Guidance on DCTs Download Now Whitepaper Signant’s Solutions Support Endpoint Reliability in Successful Pediatric Rare Disease Trial Download Case Study Case Study